ORIC Pharmaceuticals Inc
The Associate Director, CMC Project Management leads end‑to‑end CMC strategy and cross‑functional integration for a clinical‑stage biopharma, overseeing budgets, timelines, external manufacturing partnerships, and regulatory deliverables to drive product commercialization. Reporting to the Senior Director, the role acts as the program’s CMC general manager, ensuring alignment with clinical, regulatory, and commercial milestones.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2014
ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies that target cancer resistance mechanisms. The company's pipeline includes rinzimetostat and enozertinib, which are being evaluated in clinical trials for cancers such as prostate cancer and non-small cell lung cancer (NSCLC). ORIC's resistance platform addresses innate, acquired, and bypass resistance to improve the efficacy and duration of existing cancer treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ORIC Pharmaceuticals Inc.
22% above the average for this role
Manager, CMC Project Management
Crescent Biopharma
Senior Director, CMC Development, Biologics
Flagship Pioneering, Inc.
Executive Director, Global CMC Lead
Revolution Medicines
Senior Manager / Associate Director, CMC Project Management
Pulmovant
Director of CMC
Shennon Biotechnologies Inc.
Regulatory Affairs CMC Lead
Gilead Sciences